How to Deal with Side Effects of Wegovy Without Guessing

The side-effect picture from the STEP 1 trial and what it means day to day

The STEP 1 trial, published in the New England Journal of Medicine, enrolled 1,961 adults with obesity over 68 weeks and gave the clearest early picture of how semaglutide behaves at the 2.4mg maintenance dose. Gastrointestinal symptoms were the most common: nausea affected around 44% of participants on semaglutide compared with roughly 16% on placebo. Diarrhoea, vomiting and constipation followed. The crucial finding is timing: the majority of these events were mild to moderate in severity, and their peak coincided with dose increases, not with steady-state treatment. In plain terms, your gut is adjusting to a medicine that slows how quickly food leaves the stomach, and it tends to voice its objection loudest in the first week or two of a new dose.

Practically, that means eating smaller portions helps considerably. Rich, fatty or very spicy food becomes harder work when gastric emptying is slowed, so many people find it easier to eat plain, protein-led meals during the early weeks. Staying well hydrated matters more than usual, especially if nausea is putting you off drinking. The NHS's semaglutide patient information page recommends avoiding lying down straight after eating and suggests splitting meals into smaller amounts spread across the day. These are not dramatic lifestyle changes; they are small practical adjustments that sit alongside normal eating. If nausea remains difficult after the first couple of weeks at a stable dose, our prescribers have put together a practical guide on managing it, because slowing the titration schedule is a recognised option and no one should feel they have to push through on a rigid timetable.

For targeted, practical detail on dealing with semaglutide nausea specifically, our prescribers have answered the most common questions in one place.

Side effects that need prompt attention, and when to call for help

Most Wegovy side effects are self-limiting, but a small number require medical attention quickly. On 29 January 2026, the MHRA issued a Drug Safety Update for GLP-1 receptor agonists (the class that includes semaglutide) specifically highlighting acute pancreatitis as an infrequent but potentially serious side effect. The symptom to act on is severe, persistent stomach pain that travels towards the back, with or without vomiting. That symptom pattern warrants urgent medical assessment, not a wait-and-see approach. You can report any suspected side effects through the MHRA's Yellow Card scheme, which helps regulators track safety signals in real-world use.

Other side effects worth knowing: gallbladder problems can occur and may present as upper-right abdominal pain; dehydration from persistent vomiting or diarrhoea can put strain on the kidneys; and in people with a history of diabetic retinopathy, sudden vision changes should be reported to a clinician. Allergic reactions are rare but possible. None of these are reasons to avoid treatment, they are reasons to have a clinical team you can reach. At nume, aftercare runs seven days a week precisely because questions about how to deal with Wegovy side effects don't only arise on weekday mornings. You can reach us at any time through our support team.

For constipation specifically, which sits in a different register from nausea and is often underestimated, there is a dedicated practical guide on the site covering fibre, hydration and movement strategies backed by the same evidence base.

Why the cost of properly managed treatment matters when side effects are part of the picture

This is a price-context page, so here is the honest answer about Wegovy costs in the UK. Since Eli Lilly revised Mounjaro pricing in September 2025, the broader private GLP-1 market has seen pricing shift noticeably; Wegovy private pricing typically sits in a range reported by providers as roughly £149–£375 per month depending on dose and supplier. What those headline figures often exclude is the clinical infrastructure around the medicine itself: the consultation that determines whether treatment is appropriate, dose-review support when side effects appear, and aftercare access when something feels off mid-week. A low list price rarely includes all of those.

nume's position on this is deliberately straightforward. We are not the cheapest option available, and that is a considered choice rather than an oversight. What we include in one transparent price: a free consultation, a GPhC-registered Independent Prescriber reviewing it the same day, the prescription, the medicine, and free next-working-day delivery via DPD in plain, unbranded packaging, the pen arrives in a box that gives nothing away. On top of that, 7-day aftercare with no additional charge. No subscription, no automatic renewals. For a medicine where side effects often prompt questions that need a real clinical answer, the aftercare component is not a bolt-on: it is the part of the service that makes the rest of it safe. Current treatment pricing is shown on our treatment page.

If you want to understand how Wegovy pricing sits across the market, our detailed cost breakdown lays that out factually. And for a longer view on whether the treatment represents good value relative to its clinical outcomes, our cost-effectiveness analysis is worth reading before you commit.

Why 'cheapest' is the wrong filter for managing a prescription medicine's side effects

The side effects of Wegovy are real, documented and manageable, but they are best managed with clinical support, not in isolation. That basic fact reframes what matters most when choosing a provider. A provider without aftercare infrastructure leaves you ringing 111 at 9pm over nausea that a prescriber could have addressed in minutes. The MHRA's guidance on GLP-1 medicines stresses that these are prescription-only treatments requiring proper clinical assessment and ongoing oversight; that is the regulatory position, not a sales line.

Discount codes and unusually low prices for prescription GLP-1 medicines are a red flag rather than a saving, and if you are comparing pharmacies on price alone it is worth understanding what clinical support each one actually includes before making a decision. Unverified sellers offering these medicines without a proper clinical pathway have been the focus of significant MHRA enforcement action. Any legitimate online pharmacy can be checked on the GPhC register, our GPhC premises registration number is 9012878, verifiable directly at the GPhC register. That verification takes thirty seconds and is the most useful thing you can do before handing over any payment. Saving £20 on a pen and having no one to call when you feel unwell is not a good trade. Start with the consultation, and build from there. Start your free consultation here.